Spatial clustering of motor neuron disease mortality in Western Mediterranean countries, 2003–2022
Abstract
Background: Motor neuron diseases (MND) are a group of rare, progressive neurodegenerative disorders with marked geographic variability, suggesting the potential influence of environmental and contextual factors. However, evidence on spatial patterns at a high geographical resolution in Europe remains limited. This study aims to assess the spatial distribution and clustering of MND mortality across Western Mediterranean Europe.
Methods: Mortality data (ICD-10: G12.2) from 2003–2022 were obtained for France, Italy, Spain, and Portugal at the NUTS3 level (n = 288 regions). Age-standardized mortality rates and standardized mortality ratios were calculated. Spatial autocorrelation was assessed using Moran’s I (spatial autocorrelation measure), and local clustering was identified using Local Indicators of Spatial Association.
Results: Mortality rates increased over time in all countries, particularly in Portugal. A strong and significant spatial autocorrelation was observed (Moran’s I = 0.62, p < 0.001), indicating a non-random spatial distribution. Clustering was slightly more pronounced in men (I = 0.60) than in women (I = 0.53). Local spatial analysis identified significant high-risk clusters in northwestern France and central regions, while extensive low-risk clusters were observed across Spain and different parts of Portugal. These patterns were consistent in both sexes, although clustering was clearly defined in men, whereas women showed a more diffuse spatial distribution with a higher presence of local outliers, particularly in Italy.
Conclusions: MND mortality shows a clear and non-random spatial structure across Western Mediterranean Europe, with consistent clusters of high and low risk. These findings support the hypothesis that shared environmental or territorial factors may contribute to the geographic distribution of the disease. Further research is needed to explore potential environmental exposures underlying these patterns.
Key messages: • MND mortality shows strong spatial clustering (Moran’s I = 0.62), highlighting geographic inequalities across Western Mediterranean populations.
• Persistent high- and low-risk clusters suggest environmental and territorial determinants relevant for targeted public health action.
Related
- Trends in cardiovascular disease mortality and burden in Albania, 1990-2023: a comparison with Southeastern European countries
- Mortality dynamics of West Nile virus and Lyme disease in the United States : Temporal, spatial, and socioeconomic dimensions (2003–2021)
- Thermal variability and the geography of optimal temperature for child survival: childhood respiratory-infection mortality in 171 countries: a systematic analysis of the Global Burden of Disease Study 2023 and the C-LSAT high-resolution climate dataset
- Motor neuron disease in France (2010-2021): incidence, mortality, and spatial disparities
- Cardiovascular disease mortality in a Central-West Brazilian capital: A spatial, temporal, and ecological analysis
BibTeX
@article{diaz2026spatial,
title = {{Spatial clustering of motor neuron disease mortality in Western Mediterranean countries, 2003–2022}},
author = {G Sánchez Díaz and G Arias Merino and F Escobar and E Gallego and R Sarmiento and A Villaverde Hueso and V Alonso Ferreira},
journal = {The European Journal of Public Health},
year = {2026},
month = oct,
doi = {10.1093/eurpub/ckag169.957},
url = {https://doi.org/10.1093/eurpub/ckag169.957},
note = {CC BY-NC 4.0},
}
RIS
TY - JOUR
TI - Spatial clustering of motor neuron disease mortality in Western Mediterranean countries, 2003–2022
AU - G Sánchez Díaz
AU - G Arias Merino
AU - F Escobar
AU - E Gallego
AU - R Sarmiento
AU - A Villaverde Hueso
AU - V Alonso Ferreira
PY - 2026
DA - 2026/10/01
JO - The European Journal of Public Health
DO - 10.1093/eurpub/ckag169.957
UR - https://doi.org/10.1093/eurpub/ckag169.957
AB - Background: Motor neuron diseases (MND) are a group of rare, progressive neurodegenerative disorders with marked geographic variability, suggesting the potential influence of environmental and contextual factors. However, evidence on spatial patterns at a high geographical resolution in Europe remains limited. This study aims to assess the spatial distribution and clustering of MND mortality across Western Mediterranean Europe. Methods: Mortality data (ICD-10: G12.2) from 2003–2022 were obtained for France, Italy, Spain, and Portugal at the NUTS3 level (n = 288 regions). Age-standardized mortality rates and standardized mortality ratios were calculated. Spatial autocorrelation was assessed using Moran’s I (spatial autocorrelation measure), and local clustering was identified using Local Indicators of Spatial Association. Results: Mortality rates increased over time in all countries, particularly in Portugal. A strong and significant spatial autocorrelation was observed (Moran’s I = 0.62, p < 0.001), indicating a non-random spatial distribution. Clustering was slightly more pronounced in men (I = 0.60) than in women (I = 0.53). Local spatial analysis identified significant high-risk clusters in northwestern France and central regions, while extensive low-risk clusters were observed across Spain and different parts of Portugal. These patterns were consistent in both sexes, although clustering was clearly defined in men, whereas women showed a more diffuse spatial distribution with a higher presence of local outliers, particularly in Italy. Conclusions: MND mortality shows a clear and non-random spatial structure across Western Mediterranean Europe, with consistent clusters of high and low risk. These findings support the hypothesis that shared environmental or territorial factors may contribute to the geographic distribution of the disease. Further research is needed to explore potential environmental exposures underlying these patterns. Key messages: • MND mortality shows strong spatial clustering (Moran’s I = 0.62), highlighting geographic inequalities across Western Mediterranean populations. • Persistent high- and low-risk clusters suggest environmental and territorial determinants relevant for targeted public health action.
SN - 1101-1262
SN - 1464-360X
ER -